MIFEGYMISO

linepharma international limited🇨🇦 Health Canada

Approval Id: e81ce616d1388495
Drug Approval Canada Name: MIFEGYMISO
Product Name: MIFEGYMISO
Status: Marketed
Status Date: 2017-01-10
Original Market Date: 2017-01-10
Din: 02444038
Drug Class: Human
Dosage Form: Tablet , Kit
Route Of Administration: Buccal , Oral
Schedule: Prescription
Ahfs: 56:28.28
Atc Original: G03XB51 MIFEPRISTONE, COMBINATIONS
Atc Name: g 03 xb 51
Aig Number: 0257170001
Company Name: linepharma international limited
Company Address: 16 Upper Woburn Place, London, Greater London, United Kingdom, WC1H0BS

MIFEPRISTONE

200 MG

MISOPROSTOL

200 MCG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e81ce616d1388495

Type

Standard